Available Until 3/25/2025
View Cart

Ketamine Use in Special (K) Populations - The Kritically Ill

ACPE Activity Number: 0204-0000-23-062-H01-P
Release Date: 03/25/2023
Expiration Date: 03/25/2025
Activity Type: Knowledge-based
CE Credits:  0.5 contact hour, no partial credit
Activity Fee: Member – Free / Non-Member – Not Available 

Activity Overview 

Pharmacists providing care for patients who require acute pain treatment or procedural sedation face evolving standards of care.  As a result, many pharmacists are unaware of and do not practice according to the most current guidelines and evidence.  With the most current information and effective practice strategies, pharmacists can improve their treatment of patients with acute pain and sedation needs.     

ACPE Provider with Commendation logo

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

These activities were planned to meet the educational needs of pharmacists in the critical care setting involved in acute management of patient pain, sedation, and agitation. 

After completing this activity, the learner should be able to… 

  • Discuss the advantages and disadvantages of ketamine uses in critically ill patients. 

  • Identify patient populations in critical care settings who are good candidates for ketamine use. 

  • Describe dosing and monitoring considerations for ketamine in critically ill patients.  

  • Introduction and Announcements 

  • Presentation  

Maria Foy PharmD, BCPS, CPE
Advanced Clinical Pharmacist Specialist
Jefferson Abington Health 

Danielle Schulingkamp, RPh, BCPS, BCCCP
Pharmacy Care Coordinator, Critical Care/Surgical Trauma
Director, PGY2 Pharmacy Residency, Critical Care
Coordinator, PGY1 Pharmacy Residency
Jefferson Abington Health
Abington, PA  

Bhavik M. Shah, PharmD, BCPS, BCIDP
Associate Professor
Jefferson College of Pharmacy
Philadelphia, PA 

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.